Fatal hepatitis C associated fibrosing cholestatic hepatitis as a complication of cyclophosphamide and corticosteroid treatment of active glomerulonephritis

Journal Title: Annals of Hepatology - Year 2007, Vol 6, Issue 3

Abstract

Fibrosing cholestatic hepatitis (FCH) is an aggressive and usually fatal form of viral hepatitis in immunocompromised patients. It is characterized by progressive cholestasis leading to hepatic failure, and a characteristic histopathological features including: periportal fibrosis, ballooning degeneration of hepatocytes, cholestasis, with minimal inflammation. FCH has been reported almost exclusively in heavily immunosuppressed organ transplant recipients or patients with AIDS. This case report describes a previously immunocompetent patient with previously stable chronic hepatitis C who developed fibrosing cholestatic hepatitis after receiving cyclophosphamide and corticosteroids for active glomerulonephritis.

Authors and Affiliations

Faisal Saleh, Hin Ko, Jennifer Davis, Wichian Apiratpracha, James Powell, Siegfried Erb, Eric Yoshida

Keywords

Related Articles

Efficacy of maintenance subcutaneous hepatitis B immune globulin (HBIG) post-transplant for prophylaxis against hepatitis B recurrence.

Background. Patients who receive liver transplantation for chronic hepatitis B infection require long-term combination therapy with hepatitis B immunoglobulin (HBIG) and oral antiviral medication to prophylax against gra...

Association between type two diabetes and non-alcoholic fatty liver disease in youth

In the last three decades prevalence of insulin related diseases has been growing worldwide with epidemic obesity, type 2 diabetes mellitus and non alcoholic fatty liver disease. In children such epidemics are particular...

Download PDF file
  • EP ID EP77786
  • DOI -
  • Views 141
  • Downloads 0

How To Cite

Faisal Saleh, Hin Ko, Jennifer Davis, Wichian Apiratpracha, James Powell, Siegfried Erb, Eric Yoshida (2007). Fatal hepatitis C associated fibrosing cholestatic hepatitis as a complication of cyclophosphamide and corticosteroid treatment of active glomerulonephritis. Annals of Hepatology, 6(3), 186-189. https://europub.co.uk./articles/-A-77786